Acerus Pharmaceuticals Corporation announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was USD 1.085 million compared to USD 3.768 million a year ago. Operating loss was USD 22.885 million compared to USD 14.036 million a year ago. Net loss was USD 24.424 million compared to USD 16.129 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.06 a year ago.